Faheem Hyder Pottoo
- Pharmaceutical Science top 1%
- Advanced Drug Delivery Systems 8
- Biological Psychiatry top 5%
- Molecular Medicine top 5%
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery 11
-
- Synthesis and biological activity 15
-
- RNA Interference and Gene Delivery 12
-
- Neuroscience and Neuropharmacology Research 12
-
- Computational Drug Discovery Methods 11
-
- Cholinesterase and Neurodegenerative Diseases 9
-
- Natural Antidiabetic Agents Studies 8
- Co-authors
- Md. Abul BarkatHarshita Abul BarkatMd. Noushad JavedFirdos Alam KhanFarhan Jalees AhmadSarwar BegRoohi Mohi-ud-dinReyaz Hassan Mir
- Journals
- International Journal of Molecular Sciences (2 papers)European Journal of Neuroscience (2 papers)RSC Advances (3 papers)
- Partner nations
- Saudi ArabiaIndiaUnited Arab Emirates
In The Last Decade
Faheem Hyder Pottoo
119 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 132
- Pharmaceutical Science 261
- Biological Psychiatry 89
- Molecular Medicine 147
- Complementary and alternative medicine 236
- Biomaterials 330
Countries citing papers authored by Faheem Hyder Pottoo
This map shows the geographic impact of Faheem Hyder Pottoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faheem Hyder Pottoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faheem Hyder Pottoo more than expected).
Fields of papers citing papers by Faheem Hyder Pottoo
This network shows the impact of papers produced by Faheem Hyder Pottoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faheem Hyder Pottoo. The network helps show where Faheem Hyder Pottoo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Faheem Hyder Pottoo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 4 | |
| 5 | 2022 | 5 | |
| 6 | 2022 | 33 | |
| 7 | 2022 | 5 | |
| 8 | 2021 | 13 | |
| 9 | 2021 | 16 | |
| 10 | 2021 | 14 | |
| 11 | 2021 | 14 | |
| 12 | 2021 | 9 | |
| 13 | 2020 | 28 | |
| 14 | 2020 | 46 | |
| 15 | 2020 | 17 | |
| 16 | 2020 | 50 | |
| 17 | 2020 | 44 | |
| 18 | 2020 | 9 | |
| 19 | 2016 | 8 | |
| 20 | 2014 | 4 |
About Faheem Hyder Pottoo
Faheem Hyder Pottoo is a scholar working on Pharmaceutical Science, Biological Psychiatry and Toxicology, having authored 122 papers that have together received 2.5k indexed citations. Recurring topics across this work include Synthesis and biological activity (15 papers), RNA Interference and Gene Delivery (12 papers), Neuroscience and Neuropharmacology Research (12 papers), Computational Drug Discovery Methods (11 papers), Nanoparticle-Based Drug Delivery (11 papers), Cholinesterase and Neurodegenerative Diseases (9 papers), Natural Antidiabetic Agents Studies (8 papers) and Advanced Drug Delivery Systems (8 papers). The work is most often cited by research in Pharmaceutical Science (261 citations), Biological Psychiatry (89 citations) and Molecular Medicine (147 citations). Faheem Hyder Pottoo has collaborated with scholars based in Saudi Arabia, India and United Arab Emirates. Frequent co-authors include Md. Abul Barkat, Harshita Abul Barkat, Md. Noushad Javed, Firdos Alam Khan, Farhan Jalees Ahmad, Sarwar Beg, Roohi Mohi-ud-din, Reyaz Hassan Mir, Anjali Sharma and Niyaz Ahmad. Their work appears in journals such as International Journal of Molecular Sciences, European Journal of Neuroscience and RSC Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.